ABO Blood Group Type Association With COVID-19 Severity

Completed

Conditions studied: COVID-19, Blood Group Antigen Abnormality, Blood Group Incompatibilities, Diabetes Mellitus, COVID-19 Pandemic

In brief

The COVID-19 pandemic has caused a significant healthcare burden and remains a heavily researched disease entity. Originating in Wuhan, China in late 2019, SARS-CoV-2 has infected over 600 million individuals worldwide. ABO blood groups have been known to increase the human body's susceptibility to different pathogens, such as hepatitis B virus, MERS-COV, SARS-COV, norovirus, and malaria, to name a few. As such, the association of ABO blood groups and COVID-19 infection and disease severity has come into question.

Key facts

Study ID

NCT05859958

Run by

Arrowhead Regional Medical Center

People needed

599

Starts

2022-11-10

Expected to finish

2023-05-10

Last updated by the study team

2023-05-26

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• At least 18 years of age
• COVID-19 confirmed by laboratory testing (ICD10 U07.1)
• Pneumonia due to COVID-19 (ICD10 J12.82)
• Multisystem inflammatory syndrome from COVID in adults (ICD10 M35.81)
• Adult respiratory distress syndrome (ICD10 J80)
• Abnormal pulmonary function test (ICD10 R94.2)
• Intensive care unit admission for COVID-19

You may not qualify if…

• COVID-19 Diagnosis under 18 years of age
• COVID in pregnancy (O98.52, O98.511, O98.512, O98.513, O98.519, O98.53)

Where it is running

• Arrowhead Regional Medical Center — Colton, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.